ESTABLISHING CYCLIN E/CDK2 AS A NOVEL THERAPEUTIC TARGET IN INFLAMMATORY BREAST CANCER

$468,924FY2012Department of the ArmyDOD

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators